“…An SPR protein-binding biosensor assay utilising folate-binding protein (FBP) as biospecific detecting molecule was recently validated for the quantitation of PteGlu in supplemented infant formulae (Indyk, 2010), a method that complemented a previous technique exploiting a monoclonal antibody (mAb) (Boström Caselunghe & Lindeberg, 2000). As the folatedetecting species within an SPR-based assay, FBP offers several advantages relative to an antibody, including innate specificity and monomeric binding stoichiometry (Henderson,1990;Nixon, Jones, & Winzor, 2004), cross-reactivity profile towards folate vitamers (Nygren-Babol, Sternesjö, Jägerstad, & Björck, 2005) and availability from bovine milk (Parodi, 1997;Treloar, Grieve, & Nixon, 2000).…”